Class 2 Medicines Recall: Grünenthal Ltd, Palexia [tapentadol] 20 mg/ml Oral Solution (PL 21727/0054)

Grünenthal Ltd has announced a potential microbial contamination with Burkholderia contaminans, a gram-negative bacterium. Patients currently using affected batches should contact their GP to consider withdrawal, tapering of dose and review of clinical alternatives.

Source:

Medicines and Healthcare products Regulatory Agency